腺苷、利多卡因和镁减轻REBOA相关缺血再灌注损伤的初步研究
本研究为猪模型初步实验,动物经历20%控制性失血后行30分钟膈上球囊阻断,分为对照组、阻断时启动4小时ALM输注组、再灌注时启动2小时和4小时ALM输注组。再灌注后启动ALM的组别在全身再灌注后第一小时乳酸、碱剩余和pH显著改善;4小时ALM输注组总体乳酸清除优于2小时组和对照组。ALM组与对照组血流动力学参数无差异。结论认为ALM可能减轻REBOA相关缺血再灌注损伤的炎症反应,但需进一步优化治疗策略。
要点
- 再灌注后启动ALM输注(2小时或4小时)的猪在全身再灌注后第一小时乳酸、碱剩余和pH显著改善。
- 研究终点时,再灌注后启动4小时持续ALM输注的总体乳酸清除优于2小时组和对照组。
- ALM组与对照组之间血流动力学参数无差异。
- 所有ALM组在失血后接受ALM团注,随后接受相应时长的ALM输注。
- 本研究为猪模型初步实验,样本量小(对照组n=5,各ALM组n=5),结论需进一步验证。
适用人群与场景
- 猪模型:经历20%控制性失血后行30分钟膈上球囊阻断的动物。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 第一步:动物行20%控制性失血。
- 第二步:行30分钟膈上球囊阻断。
- 第三步:ALM组在失血后接受ALM团注,随后接受相应时长的ALM输注;分组为阻断时启动4小时ALM输注、再灌注时启动2小时ALM输注、再灌注时启动4小时ALM输注。
- 原文未提及ALM的具体剂量、浓度、给药途径或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:猪模型初步实验;样本量:对照组n=5,阻断时4小时ALM组n=5,再灌注时2小时ALM组n=5,再灌注时4小时ALM组n=5。
- 干预与对照:ALM组接受失血后ALM团注+相应时长ALM输注,对照组未接受ALM。
- 主要终点:生理和血流动力学参数。
- 关键结果:再灌注后启动ALM的组别在全身再灌注后第一小时乳酸、碱剩余和pH显著改善;研究终点时4小时ALM输注组总体乳酸清除优于2小时组和对照组;ALM组与对照组血流动力学参数无差异。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)初步研究。
- 局限:样本量小(每组n=5),为初步研究,结论需进一步验证;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 原文结果提示再灌注后启动ALM输注可能改善REBOA相关缺血再灌注损伤的早期生理指标(乳酸、碱剩余、pH),但血流动力学无改善。
- 本研究为猪模型初步实验,不能直接改变急诊/ICU床旁实践;ALM的剂量、途径、疗程及人体适用性均未确定,需进一步研究优化治疗策略。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA), a minimally invasive alternative to resuscitative thoracotomy, has been associated with significant ischemia reperfusion injury (IRI). Resuscitation strategies using adenosine, lidocaine, and magnesium (ALM) have been shown to mitigate similar inflammatory responses in hemorrhagic and septic shock models. This study examined the effects of ALM on REBOA-associated IRI using a porcine model.
METHODS: Animals underwent a 20% controlled hemorrhage followed by 30 minutes of supraceliac balloon occlusion. They were assigned to one of four groups: control (n = 5), 4-hour ALM infusion starting at occlusion, 2-hour (n = 5) and 4-hour (n = 5) interventional ALM infusions starting at reperfusion. Adenosine, lidocaine, and magnesium cohorts received a posthemorrhage ALM bolus followed by their respective ALM infusion. Primary outcomes for the study assessed physiologic and hemodynamic parameters.
RESULTS: Adenosine, lidocaine, and magnesium infusion after reperfusion cohorts demonstrated a significant improvement in lactate, base deficit, and pH in the first hour following systemic reperfusion. At study endpoint, continuous ALM infusion initiated after reperfusion over 4 hours resulted in an overall improved lactate clearance when compared with the 2-hour and control cohorts. No differences in hemodynamic parameters were noted between ALM cohorts and controls.
CONCLUSION: Adenosine, lidocaine, and magnesium may prove beneficial in mitigating the inflammatory response seen from REBOA-associated IRI as evidenced by physiologic improvements early during resuscitation. Despite this, further refinement should be sought to optimize treatment strategies.
参考来源
- Conner J, Lammers D, Holtestaul T, et al. Combatting ischemia reperfusion injury from resuscitative endovascular balloon occlusion of the aorta using adenosine, lidocaine and magnesium: A pilot study. J Trauma Acute Care Surg. 2021. PMID: 34446655. doi:10.1097/TA.0000000000003388
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。